Literature DB >> 10791877

Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load.

W J Miley1, K Suryanarayana, A Manns, R Kubota, S Jacobson, J D Lifson, D Waters.   

Abstract

We have developed a quantitative real-time PCR assay for HTLV-I DNA. This assay approach uses real-time monitoring of fluorescent signal generation as a consequence of Taq-mediated amplification of specific target sequences to allow real-time kinetic analysis of amplicon production. This kinetic approach yields excellent sensitivity and an extremely broad linear dynamic range, and ensures that quantitation is based on analysis during the exponential phase of amplification, regardless of the input template copy number. The HTLV-I DNA assay has a nominal threshold sensitivity of 10 copy Eq/reaction, although single-copy plasmid template can be detected at frequencies consistent with statistical prediction. The linear dynamic range is in excess of 5 logs. Interassay reproducibility averages 14% (coefficient of variation) for control templates over a range of 10(1) to 10(6) copy Eq/reaction and 25%, based on studies of extraction and analysis of replicate aliquots of PBMC specimens from HTLV-I-infected subjects. The primer/probe combination targets tax sequences conserved across described HTLV-I and HTLV-II isolates. Parallel quantitation in the same samples of an endogenous sequence present at a known copy number per cell allows normalization of results for potential variation in DNA recovery. Availability of this assay should facilitate studies of basic pathogenesis and clinical evaluation of HTLV-I and HTLV-II infection, as well as assessment of therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10791877     DOI: 10.1089/088922200308891

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Real-time detection of gene promoter activity: quantitation of toxin gene transcription.

Authors:  K Jeyaseelan; D Ma; A Armugam
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

2.  In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.

Authors:  Lee R Silverman; Andrew J Phipps; Andy Montgomery; Soledad Fernandez; Tomonori Tsukahara; Lee Ratner; Michael D Lairmore
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

3.  Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display.

Authors:  David L Jaye; Frederick S Nolte; Luca Mazzucchelli; Cissy Geigerman; Adil Akyildiz; Charles A Parkos
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.

Authors:  Vanessa Adaui; Kristien Verdonck; Iván Best; Elsa González; Martín Tipismana; Jorge Arévalo; Guido Vanham; Miguel Campos; Mirko Zimic; Eduardo Gotuzzo
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643

5.  Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.

Authors:  Andrew Mone; Shannon Puhalla; Susan Whitman; Robert A Baiocchi; Julio Cruz; Tamara Vukosavljevic; Amy Banks; Charles F Eisenbeis; John C Byrd; Michael A Caligiuri; Pierluigi Porcu
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

6.  Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.

Authors:  Rashade A H Haynes; Andrew J Phipps; Brenda Yamamoto; Patrick Green; Michael D Lairmore
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

7.  Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.

Authors:  Hajime Hiraragi; Seung-Jae Kim; Andrew J Phipps; Micol Silic-Benussi; Vincenzo Ciminale; Lee Ratner; Patrick L Green; Michael D Lairmore
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination.

Authors:  Britta Moens; Giovanni López; Vanessa Adaui; Elsa González; Lien Kerremans; Daniel Clark; Kristien Verdonck; Eduardo Gotuzzo; Guido Vanham; Olivier Cassar; Antoine Gessain; Anne-Mieke Vandamme; Sonia Van Dooren
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

9.  The Prevalence of Human T-Cell lymphotropic Virus Type 1 in Pregnant Women and Their Newborns.

Authors:  A Hamedi; F Akhlaghi; Z Meshkat; M Sezavar; H Nomani; M Meshkat
Journal:  ISRN Obstet Gynecol       Date:  2012-11-14

10.  HTLV-2 infection in Manaus, Brazil: first description of HTLV-2c subtype in an urban area of the Western Amazon region.

Authors:  Gemilson Soares Pontes; Hygor Halyson Figueiredo Ribeiro; Diana Mota Toro; José Pereira de Moura Neto; Victor Souza; Maria Edilene Martins de Almeida; Valdinete Alves do Nascimento; Cristovão Alves da Costa; Felipe Gomes Naveca; Mike Santos; Antonio Carlos Rosário Vallinoto
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-13       Impact factor: 1.581

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.